A unique perspective: How clinicians can help health tech innovation thrive
March 27, 2024
.svg)
May 21, 2026
Digital transformation in the NHS is often framed as an efficiency play. But that framing misses the point, and, crucially, it doesn’t align with how funding decisions are actually made.
Commissioners do not fund efficiency in the abstract. They fund measurable system impact: reduced pressure on waiting lists, safer clinical pathways, and demonstrable improvements in how demand flows through the system. If return on investment (ROI) cannot be evidenced clearly (financially, operationally, and clinically) a digital initiative risks being confined to the familiar cycle of short-term pilots and limited adoption.
This matters more now than ever. With elective backlogs still in the millions and workforce constraints unlikely to ease in the near term, the NHS cannot afford digital tools that simply layer on top of existing processes. Transformation must be structural. And if it is structural, it must be measurable and measurable must include a clear ROI..
So what does meaningful ROI actually look like in a digital pathway transformation?
One of the most persistent issues in digital health is the tendency to equate usage with success. High login numbers, increasing volumes of Advice & Guidance (A&G) requests, or positive user feedback are often presented as proof of value.
They aren’t.
At best, these are indicators of adoption. At worst, they mask the absence of genuine transformation. A system that digitises referrals but does not change clinical decision-making or demand patterns is not delivering ROI, it is simply moving inefficiency into a new format.
Meaningful ROI in an NHS pathway transformation needs to be anchored in four outcome domains.
First, activity diversion.
A core objective of digital A&G is to shift care upstream, resolving cases in primary care that would previously have resulted in a referral. This should be measurable as a reduction in first outpatient attendances and unnecessary follow-ups. In some specialties, well-implemented A&G pathways have demonstrated that a significant proportion of cases (often 30–60%) can be managed without onward referral when timely specialist input is available.
Second, capacity released.
The NHS is not short of demand; it is short of capacity. Any credible ROI model must show how consultant time is being freed up. That might mean fewer clinic slots required, faster decision-making, or reduced administrative burden across both primary and secondary care. Importantly, this capacity should be visible in operational data, clinic utilisation, waiting list growth rates, and workforce allocation, not treated as a theoretical benefit.
Third, waiting list impact.
Transformation should change demand flow, not just increase throughput. If a digital pathway is working, you should see a slowing of referral growth, shorter times from referral to decision, and fewer patients entering secondary care unnecessarily. Given that NHS waiting lists have exceeded seven million in recent years, even marginal improvements in referral appropriateness can have a material system-wide effect.
Finally, risk reduction and governance.
This is often overlooked but critically important. Structured, auditable communication between primary and secondary care reduces clinical risk. Standardised documentation improves continuity and accountability. At Integrated Care Board (ICB) level, this translates into stronger oversight and more defensible decision-making.
Taken together, these outcomes (not usage metrics) define ROI.
A surprisingly common failure point in digital transformation is not the technology itself, but the absence of a credible baseline.
Without pre-implementation data, post-launch reporting lacks context. A reduction in outpatient referrals, for example, is meaningless unless you know what the previous conversion rate from A&G to referral looked like. Similarly, improvements in response times cannot be evaluated without understanding historical delays.
Before any rollout, systems should be capturing:
This is not just a technical exercise, it is about establishing a shared understanding of the problem. Too often, digital solutions are introduced without a clear articulation of what they are trying to change.
A strong baseline turns transformation from a narrative into a measurable intervention. It allows commissioners to compare like-for-like and, crucially, to defend investment decisions with evidence rather than anecdote.
The NHS does not lack pilots. It lacks scale.
Many digital initiatives demonstrate early promise but fail to translate into system-wide change. The reason is usually the same: they measure success at the wrong level.
Pilot metrics tend to focus on localised indicators—number of queries submitted, user satisfaction, or adoption rates within a single specialty. These are useful for testing feasibility, but they do not answer the question commissioners are asking: what impact does this have across the system?
To evidence ROI at that level, measurement needs to shift.
Instead of counting activity, systems should be reporting:
This is where many digital programmes struggle. It requires not just data collection, but data integration, bringing together primary care, secondary care, and administrative datasets into a coherent view.
But without this shift, transformation remains local. And local transformation, however successful, rarely secures long-term funding.
One of the more uncomfortable truths in NHS transformation is that ROI rarely appears as direct, cashable savings.
Reducing outpatient appointments does not immediately reduce budgets. Consultant salaries are still paid. Infrastructure remains in place. This has led some to question whether digital transformation truly delivers financial return.
That framing is too narrow.
In practice, ROI is more often realised as cost avoidance, preventing additional expenditure that would otherwise be required to meet rising demand. This is particularly relevant given the sustained growth in referrals and the increasing reliance on locum staff to manage capacity gaps.
Cost avoidance can be quantified in several ways:
When modelled properly, these figures provide a clear financial narrative. They show how digital pathways allow systems to absorb demand within existing budgets, rather than requiring additional funding.
For commissioners, this is often the most compelling argument. Not that transformation saves money outright, but that it prevents the system from becoming more expensive.
Even where ROI is demonstrated, many digital initiatives fail to scale. The reason is rarely clinical, it is structural.
A solution that works in one specialty, or within a single trust, does not automatically translate elsewhere. Differences in governance, workflows, and local priorities can quickly erode consistency.
For ROI to compound over time, scalability has to be designed in from the outset.
This includes:
Perhaps most importantly, transformation cannot rely on individual champions. While clinical leadership is essential, a model that depends on a handful of engaged individuals is inherently fragile.
Sustainable ROI comes from embedding new ways of working into the system itself, making them the default, not the exception.
At its core, digital pathway transformation is not about introducing new technology. It is about redesigning how demand moves through the system.
That is a fundamentally different challenge.
Digitisation makes existing processes more efficient. Transformation changes the processes altogether, shifting decision-making earlier, reducing unnecessary escalation, and ensuring that patients receive the right care in the right setting.
The distinction matters because only one of these delivers meaningful ROI.
When ROI is clearly defined, grounded in baseline data, and measured at system level, digital initiatives move beyond pilot status. They become part of the NHS’s core infrastructure, supporting not just incremental improvement, but structural change.
And in a system under sustained pressure, that is not optional. It is essential.
See how you can evidence ROI with Cinapsis.
.svg)
